Partner With Us

OnCuRNA welcomes partnering opportunities with academic and industry groups who share our vision for innovation and patient-centered care. OnCuRNA has developed a broad IP portfolio focused on the use of nanohydrogels for oncological indications with a particular interest in exploring delivery of small molecules, and macromolecules such as nucleic acids and peptides to solid tumors. We invite you to explore partnership opportunities with us to advance cancer treatment.